Lung Cancer Services
-
based in UNITED KINGDOM
EarlyCDT is a simple blood test that detects the elevated presence of autoantibodies generated by the body's immune system as a natural defence against cancer cells. EarlyCDT Lung is the world’s most thoroughly validated blood test for the detection of lung cancer and requires only a small volume of blood which can be taken ...
-
Manufactured by Alfa Chemistrybased in USA
PF-06821497 is a potent EZH2 Inhibitor which can be used for the treatment of relapsed/refractory SCLC (small cell lung cancer), castration resistant prostate cancer, and follicular lymphoma. Alfa Chemistry offers high quality of PF-06821497 which can be a potent EZH2 Inhibitor for the treatment of relapsed/refractory SCLC (small cell ...
-
based in USA
Avalia’s solid tumor preclinical program focusing on eradication of solid tumors has shown meaningful tumor regression and survival benefits in models of melanoma, glioblastoma and lung cancer and also in combination with market approved therapeutic agents and others in ...
-
based in USA
The deep learning AI model provides fast and powerful image analysis assistance to pathologists in their diagnostic tasks. CE-IVD marked Aiforia Clinical AI Models for Breast Cancer: Ki67, ER, and PR available now. CE-IVD marked Aiforia Clinical AI Model for Lung Cancer: PD-L1 available now. CE-IVD marked Aiforia Clinical AI Model for ...
-
based in USA
as screening programs for coronary artery disease and lung cancer. The service is fully digital and integrated with our colleagues in thoracic surgery and pulmonary medicine. ...
-
Manufactured by Alfa Chemistrybased in USA
Methotrexate, one of the earliest cancer chemotherapy agents, which is extensively used in the treatment of cancer, including breast cancer, leukemia, lung cancer, lymphoma, osteosarcoma and so on. The efficacy of methotrexate mainly due to its inhibitory effect on dihydrofolate reductase (DHFR)[1]. DHFR ...
-
Manufactured by Grail, Inc.based in USA
. SUMMIT aims to further evaluate GRAIL’s blood test designed to detect multiple types of cancer, including lung cancer. The participants will be people at high risk of lung and other cancers due to a significant smoking history. Participants will be followed annually for three years and then will be ...
-
Manufactured by Alfa Chemistrybased in USA
Ifosfamide has been effectively employed in the treatment of multiple cancers, including testicular cancer, soft tissue sarcoma, osteosarcoma, bladder cancer, small cell lung cancer, non-Hodgkin lymphoma, Hodgkin lymphoma, epithelial ovarian cancer, cervical carcinoma and germ cell carcinoma of ...
-
based in USA
AmpliMark is the foundational technology behind Lucence’s liquid biopsy tests. AmpliMark uses unique molecular barcodes in this error-correction technology. It is designed to improve detection of multiple mutation types like single nucleotide variants, insertions and deletions (indels), copy number variations (CNVs), fusions and microsatellite instability ...
-
Manufactured by MiraDxbased in USA
Independent of their BRCA1/BRCA2 mutational status, ...
-
Manufactured by Galera Therapeutics, Inc.based in USA
Harnessing the Anticancer Power of Hydrogen Peroxide: As cancer cells are more susceptible than normal cells to increased levels of hydrogen peroxide, we believe the conversion of radiation-generated superoxide to hydrogen peroxide by our selective dismutase mimetics can improve outcomes for patients who receive radiation ...
-
Manufactured by IMB Dx, Inc.based in SOUTH KOREA
The AlphaLiquid® platform is being widely applied in translational research to empower our understanding of tumor evolution, response to therapy and resistance mechanisms, as well as to provide insights on the clinical value of ctDNA analysis in precision ...
-
Manufactured by Kura Oncology, Inc.based in USA
Kura Oncology’s clinical trial programs represent the next step toward our goal of realizing the full potential of precision medicine. Our investigational trials are studying innovative therapeutic candidates with the potential to help patients with certain cancers live better, longer lives. ...
-
based in USA
LiquidHALLMARK® is an ultrasensitive next-generation sequencing assay for genomic profiling of a patient’s unique cancer. By requiring only a single blood sample, LiquidHALLMARK provides important information for cancer care especially when tissue by invasive biopsy is insufficient or ...
-
based in CANADA
mutations, and mutations with prognostic and diagnostic implications for care. Find It helps oncologists to tailor treatments based on the genomic mutations in their patients’ tumors for more personalized cancer ...
-
Manufactured by Lupin Limitedbased in INDIA
The NDDD team has developed a pipeline of highly differentiated and innovative new chemical entities in focused therapeutic areas of Oncology, Immunology and Metabolic ...
-
Manufactured by IMB Dx, Inc.based in SOUTH KOREA
Analysis of cancer-related genes through blood. Through a simple blood draw, key genes related to various cancer types of solid cancers (including gastric, lung, colon, breast, liver, pancreatic, ovarian and uterine cancer, as well as rare cancers such as melanoma and sarcoma) can be tested for ...
-
Manufactured by XILIS, Inc.based in USA
Xilis’ rapid and scalable patient-derived MicroOrganoSphere (MOS) technology platform enhances precision medicine and pharmaceutical drug discovery and development. Compared to conventional patient-derived models, MOS provides faster, higher-throughput, and greater cost savings, as well as more predictive and accurate results. MOS can be used in large-scale pharmacogenomic studies that are ...
-
Manufactured by Mesothelioma + Asbestos Awareness Centerbased in USA
There is no cure for mesothelioma, but clinical trials and experimental treatments offer hope for the future. In the never-ending effort to eradicate cancer, there are medical and scientific researchers constantly looking for new ways to attack this deadly disease. Many of the commonly used methods of treating cancer today were once ...
-
Manufactured by Inovotion Sasbased in FRANCE
Pharmaceutical chemical and biology researchers need to develop new methods and models to improve the predictivity of preclinical discovery phases and increase the number of good molecules in clinic. INOVOTION’s unique in vivo technology will allow you to raise the global number of drug candidates tested in clinic without increasing your ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you